An informal board of directors meeting of Novo Nordisk-CAS Research Fund was held in Beijing in the afternoon of September 24, 2014. Representing Chinese Academy of Sciences (CAS) were Drs. Tao Xu (Institute Director) and Ming-Wei Wang (Center Director), and their counterparts from Novo Nordisk (NN) included Drs. Boerge Diderichsen (Vice President), Baoping Wang (President of Novo Nordisk China R&D Center) and Rasmus Joergensen (Vice President of Novo Nordisk China R&D Center). The participants discussed in great detail as to the preparation of “NN-CAS Symposium – Translational Research in Biopharmaceuticals” to be held in November this year. Ms. Dongyao Wang (Program Officer), Division of European Affairs, Bureau of International Cooperation of CAS, was also present.